Ellume 250,000 test per day by Mar 2021, page-151

I can't find any reference to where ADO has mentioned their commercial arrangement with Ellume - specifically when payment might be made by Ellume for the delivery of anteobind.

Given that Ellume would not be generating revenue for delivery of their tests into the US until Q1 2021, is it possible that the first payment to ADO might not occur until then also?

Several posters have speculated that the Q4 2020 quarterly will see revenue from Ellume - do they know something that I don't?

While a disappointing 4c might put a short-term dampener on the SP, a positive statement in the activities report regarding revenue from Ellume might be the tonic.